- Home
- SXTP vs HSCS Comparison
SXTP vs HSCS Comparison
Compare SXTP & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SXTP
- HSCS
- Stock Information
- Founded
- SXTP 2010
- HSCS 2007
- Country
- SXTP United States
- HSCS United States
- Employees
- SXTP N/A
- HSCS N/A
- Industry
- SXTP Biotechnology: Pharmaceutical Preparations
- HSCS Medical Specialities
- Sector
- SXTP Health Care
- HSCS Health Care
- Exchange
- SXTP Nasdaq
- HSCS Nasdaq
- Market Cap
- SXTP 3.4M
- HSCS 3.7M
- IPO Year
- SXTP 2023
- HSCS 2022
- Fundamental
- Price
- SXTP $1.34
- HSCS $3.08
- Analyst Decision
- SXTP Buy
- HSCS Strong Buy
- Analyst Count
- SXTP 2
- HSCS 2
- Target Price
- SXTP $7.00
- HSCS $13.00
- AVG Volume (30 Days)
- SXTP 1.6M
- HSCS 203.5K
- Earning Date
- SXTP 08-13-2025
- HSCS 07-24-2025
- Dividend Yield
- SXTP N/A
- HSCS N/A
- EPS Growth
- SXTP N/A
- HSCS N/A
- EPS
- SXTP N/A
- HSCS N/A
- Revenue
- SXTP $802,323.00
- HSCS $4,350.00
- Revenue This Year
- SXTP $81.41
- HSCS $21,003.45
- Revenue Next Year
- SXTP $95.63
- HSCS $533.33
- P/E Ratio
- SXTP N/A
- HSCS N/A
- Revenue Growth
- SXTP 118.37
- HSCS N/A
- 52 Week Low
- SXTP $1.26
- HSCS $2.36
- 52 Week High
- SXTP $12.70
- HSCS $6.47
- Technical
- Relative Strength Index (RSI)
- SXTP 31.48
- HSCS 38.36
- Support Level
- SXTP $1.26
- HSCS $3.04
- Resistance Level
- SXTP $1.43
- HSCS $4.30
- Average True Range (ATR)
- SXTP 0.15
- HSCS 0.39
- MACD
- SXTP -0.02
- HSCS -0.12
- Stochastic Oscillator
- SXTP 6.08
- HSCS 5.93
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.